Description: Khiron Life Sciences Corp. develops cannabis products for medical purposes. It also provides cosmeceutical and nutraceutical products. The company was founded in 2017 and is headquartered in Toronto, Canada.
Home Page: khiron.ca
500 Burrard Street
Vancouver,
BC
V6C 2B5
Canada
Phone:
705 527 3564
Officers
| Name | Title |
|---|---|
| Dr. Alvaro Francisco Torres | Co-Founder, CEO & Director |
| Ms. Franziska Katterbach | Pres of Khiron Europe |
| Mr. Swapan Kakumanu ACA, ACWA, CGA | Corp. Sec. |
| Ms. Helen Bellwood A.C.A. | Interim Chief Financial Officer |
| Mr. Manuel Buendia | VP of Operations |
| Mr. Luis Chavez | Country Mang. of Mexico |
| Mr. Marco Algorta | Country Mang. of Uruguay |
| Mr. Juan Diego Alvarez | VP of Regulations |
Exchange: OTCQX
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4495 |
| Price-to-Sales TTM: | 0.5404 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |